FBT:NYE-First Trust NYSE Arca Biotechnology Index Fund (USD)

ETF | Health |

Last Closing

USD 171.23

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

ETFs Containing FBT

FHM:CA 0.00 % 0.78 %

N/A

N/A
FBT:CA First Trust NYSE Arca Bio.. 0.00 % 0.00 %

+0.06 (+0.19%)

CAD 1.83M

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.02% 71% C- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.02% 71% C- 87% B+
Trailing 12 Months  
Capital Gain 10.13% 100% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.13% 100% F 53% F
Trailing 5 Years  
Capital Gain 12.08% 38% F 57% F
Dividend Return 1.45% 37% F 4% F
Total Return 13.53% 38% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 1.30% 33% F 38% F
Dividend Return 1.63% 33% F 29% F
Total Return 0.33% 42% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 12.24% 86% B+ 74% C
Risk Adjusted Return 13.30% 38% F 29% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.